iThera in the news

iThera Medical reports initiation of fifth clinical site in ongoing study for the non-invasive assessment of inflammatory bowel disease

October 18, 2022

Munich, DE – Medical device company iThera Medical announces that the fifth site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD).

iThera Medical leads €1.6m project to develop novel machine learning-assisted optoacoustic imaging of neuromuscular disease

May 17, 2022

Medical device company iThera Medical announces the kickoff of the technology innovation project SMART-3D funded by the Bavarian Research Foundation. Commenced on 01 May 2022, the project aims to develop an innovative new approach to monitor neuromuscular disease in pediatric patients through the company’s proprietary optoacoustic imaging technology and next-generation 3D image reconstruction assisted by machine learning.

iThera Medical awarded major European grant to translate its optoacoustic imaging technology from research to routine clinical use

March 30, 2022

Munich, DE – Medical device company iThera Medical announces successful funding of the Horizon Europe technology innovation project FRONTIER. Under the EIC Accelerator program, Europe’s largest and most selective public funding program for breakthrough innovation projects, the EU will provide €2.5 million grant funding and up to €15 million equity. Through this project, iThera Medical will translate its proprietary optoacoustic imaging technology from a research environment to application in routine clinical imaging, thus providing clinicians worldwide with a powerful new diagnostic tool. 

iThera Medical introduces the world’s first transmission ultrasound system

October 6, 2021

Imaging device company iThera Medical announces the launch of its new inVision TRIO preclinical optoacoustic imaging system. The inVision TRIO is the first imaging system in the world that incorporates transmission ultrasound computed tomography (TUCT) and expands the field of biomedical applications addressable using iThera Medical’s optoacoustic imaging systems.

iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease

September 23, 2021

Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD).

iThera Medical leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis

September 13, 2021

Medical device company iThera Medical announces the kickoff of the Bavarian state-funded technology innovation project DeepOPUS. The project aims to augment the company’s proprietary optoacoustic imaging technology using AI technology, developing it into a quantitative diagnostic method for inflammatory bowel disease (IBD) and beyond.